205 related articles for article (PubMed ID: 15091230)
1. Supporting cells as a target of cisplatin-induced inner ear damage: therapeutic implications.
Ramírez-Camacho R; García-Berrocal JR; Buján J; Martín-Marero A; Trinidad A
Laryngoscope; 2004 Mar; 114(3):533-7. PubMed ID: 15091230
[TBL] [Abstract][Full Text] [Related]
2. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E reduces cisplatin ototoxicity.
Kalkanis JG; Whitworth C; Rybak LP
Laryngoscope; 2004 Mar; 114(3):538-42. PubMed ID: 15091231
[TBL] [Abstract][Full Text] [Related]
4. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
Feghali JG; Liu W; Van De Water TR
Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
[TBL] [Abstract][Full Text] [Related]
5. Cochlear structure and function after round window application of ototoxins.
Bauer CA; Brozoski TJ
Hear Res; 2005 Mar; 201(1-2):121-31. PubMed ID: 15721567
[TBL] [Abstract][Full Text] [Related]
6. Blebs in inner and outer hair cells: a pathophysiological hypothesis.
Ramírez-Camacho R; García-Berrocal JR; Trinidad A; Verdaguer JM; Nevado J
J Laryngol Otol; 2008 Nov; 122(11):1151-5. PubMed ID: 18184450
[TBL] [Abstract][Full Text] [Related]
7. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells.
Kopke RD; Liu W; Gabaizadeh R; Jacono A; Feghali J; Spray D; Garcia P; Steinman H; Malgrange B; Ruben RJ; Rybak L; Van de Water TR
Am J Otol; 1997 Sep; 18(5):559-71. PubMed ID: 9303151
[TBL] [Abstract][Full Text] [Related]
8. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
9. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
Nader ME; Théorêt Y; Saliba I
Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-induced hearing loss does not correlate with intracellular platinum concentration.
Ramírez-Camacho R; Fernández DE; Verdaguer JM; Gómez MM; Trinidad A; García-Berrocal JR; Corvillo MA
Acta Otolaryngol; 2008 May; 128(5):505-9. PubMed ID: 18421602
[TBL] [Abstract][Full Text] [Related]
11. Oral ethanol potentiates the loss of outer hair cells in cisplatin-exposed rats.
Madnani D; Li G; Frenz CM; Frenz DA
Otolaryngol Head Neck Surg; 2007 Aug; 137(2):327-31. PubMed ID: 17666265
[TBL] [Abstract][Full Text] [Related]
12. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
[TBL] [Abstract][Full Text] [Related]
13. Light microscopy study of cisplatin-induced ototoxicity in rats.
de Freitas MR; de Castro Brito GA; de Carvalho JV; Gomes RM; Barreto Martins MJ; de Albuquerque Ribeiro R
J Laryngol Otol; 2009 Jun; 123(6):590-7. PubMed ID: 19144244
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of different approaches for establishing cisplatin-induced cochlear lesions in mice.
He J; Yin S; Wang J; Ding D; Jiang H
Acta Otolaryngol; 2009 Dec; 129(12):1359-67. PubMed ID: 19922082
[TBL] [Abstract][Full Text] [Related]
15. Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig.
Laurell G; Ekborn A; Viberg A; Canlon B
Audiol Neurootol; 2007; 12(3):170-8. PubMed ID: 17259704
[TBL] [Abstract][Full Text] [Related]
16. [Histocochleographic studies of the late toxicity of cisplatin].
Löw M; Federspil P
HNO; 1992 Jul; 40(7):271-6. PubMed ID: 1500305
[TBL] [Abstract][Full Text] [Related]
17. The role of antioxidants in protection from ototoxic drugs.
Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
[TBL] [Abstract][Full Text] [Related]
18. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
Lynch ED; Gu R; Pierce C; Kil J
Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563
[TBL] [Abstract][Full Text] [Related]
19. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS.
Li G; Liu W; Frenz D
Neurotoxicology; 2006 Jan; 27(1):22-30. PubMed ID: 16125245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
